Lamdong Pharmaceutical JSC (HNX: LDP)

HNX: LDP Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2019	FY 2018
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	12,450	16,205	16,619	65,159	28,257	10,386
Short-Term Investments	5,775	3,121	1,788	-	-	-
Cash & Short-Term Investments	18,225	19,326	18,407	65,159	28,257	10,386
Cash Growth	-	4.99%	-71.75%	130.59%	172.07%	-3.11%
Accounts Receivable	14,366	21,205	21,415	23,286	53,300	38,088
Other Receivables	11,476	11,216	10,819	432.72	1,143	2,181
Receivables	25,843	32,421	32,234	23,719	54,443	40,269
Inventory	38,208	37,751	55,919	54,575	94,621	112,228
Prepaid Expenses	562.93	442.65	957.04	284.73	599.99	-
Other Current Assets	51,508	50,273	51,458	545.85	958.51	7,561
Total Current Assets	134,348	140,214	158,976	144,283	178,879	170,443
Property, Plant & Equipment	41,295	46,329	55,742	60,718	87,627	80,166
Long-Term Investments	-	-	-	-	5	5
Other Intangible Assets	106.31	229.47	491.92	740.21	4,260	4,887
Other Long-Term Assets	7,754	8,000	13,164	10,180	10,933	11,812
Total Assets	183,503	194,773	228,374	215,921	281,704	267,314
Accounts Payable	18,658	23,549	31,801	13,964	59,830	101,862
Accrued Expenses	11,729	8,334	7,216	3,345	10,864	2,097
Short-Term Debt	50,093	65,960	70,298	29,960	90,679	49,210
Current Income Taxes Payable	2,633	562.22	1,063	7,209	5,959	775.44
Current Unearned Revenue	66	-	60	72	720	-
Other Current Liabilities	2,399	2,282	3,138	3,933	2,863	1,997
Total Current Liabilities	85,578	100,687	113,574	58,483	170,915	155,941
Long-Term Debt	-	-	591.64	2,339	9,980	16,783
Other Long-Term Liabilities	1,770	1,720	1,720	1,720	5,519	6,352
Total Liabilities	87,348	102,407	115,886	62,541	186,415	179,076
Common Stock	127,032	127,032	127,032	127,032	78,300	78,300
Retained Earnings	-30,876	-34,666	-14,543	26,348	16,086	9,642
Treasury Stock	-0.32	-0.32	-0.32	-0.32	-0.32	-0.32
Comprehensive Income & Other	-	-	-	-	904.23	297.31
Shareholders' Equity	96,155	92,366	112,489	153,380	95,289	88,238
Total Liabilities & Equity	183,503	194,773	228,374	215,921	281,704	267,314
Total Debt	50,093	65,960	70,889	32,299	100,660	65,992
Net Cash (Debt)	-31,867	-46,634	-52,482	32,860	-72,402	-55,606
Net Cash Per Share	-2507.36	-3671.83	-4132.07	2586.61	-9245.07	-7103.08
Filing Date Shares Outstanding	12.7	12.7	12.7	12.7	7.83	7.83
Total Common Shares Outstanding	12.7	12.7	12.7	12.7	7.83	7.83
Working Capital	48,770	39,527	45,402	85,800	7,964	14,503
Book Value Per Share	7569.41	7271.08	8855.18	12073.06	12167.08	11272.61
Tangible Book Value	96,049	92,136	111,997	152,640	91,029	83,351
Tangible Book Value Per Share	7561.04	7253.02	8816.45	12014.79	11623.13	10648.33
Construction In Progress	-	-	690.2	-	-3,102	-

Source: S&P Capital IQ. Standard template. Financial Sources.